Tag: Health care industry
-
Most Americans aren’t anti-vaccine. They’re uncertain — and that’s a growing public health challenge
The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.
-
BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment
BioMarin will acquire Alesta Therapeutics for $275 million upfront, bolstering BioMarin’s unit focused on rare skeletal conditions.
-
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 50%
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
-
After a long job search, this 45-year-old is ditching corporate for nursing school—she wishes she’d done it earlier
Kristy Layden spent over a year job searching after losing her job as a senior manager in e-commerce and fulfillment. Now she’s going to nursing school instead.
-
Hims & Hers CEO says FTC lawsuit misunderstands how the company works
Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC’s lawsuit against the company, compounded GLP-1 drugs and AI.
-
The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
-
Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’
Novo Nordisk CEO defended the company’s decision to sue rival Eli Lilly over its weight-loss drug advertising.
-
Trump administration ends Medicaid, CHIP funding for gender-affirming care for children
Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.
-
We’re lifting our price target on Cardinal Health after issuing rosy profit guidance
The quarter wasn’t totally clean, but strong profitability matters the most.
-
Trump wants to split the MMR vaccine. Experts say that’s unlikely — and comes with consequences
Doctors and other experts say that splitting the measles, mumps and rubella shot has no scientific basis and is unlikely to get off the ground.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
